At a time when many life sciences companies are shrinking their workforce, Vertex Pharmaceuticals Inc. has once again grown ...
With a market cap of $118.7 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a global biotechnology leader specializing ...
Vertex Pharmaceuticals will soon lose a member ... three-quarters of which are in Massachusetts. The news was announced during the company's fourth quarter and full-year financial results on ...
What to know about MA-based Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotech company based in Boston, Massachusetts. Its headquarters are in Boston's Seaport neighborhood, and it also ...
Moderna, Inc.; and Entrada Therapeutics, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.
That’s the opinion of top Vertex Pharmaceuticals executives and several market analysts about the Boston-based company ... chief executive of the Massachusetts Association of Health Plans ...
Federal officials approved a new non-opioid painkiller developed by a Boston pharmaceutical company ... Food and Drug Administration approved Vertex Pharmaceuticals‘s Journavx, known by the ...
Learn more about whether Alnylam Pharmaceuticals, Inc. or Vertex Pharmaceuticals Incorporated is a better investment based on ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alphatec Holdings (ATEC – Research Report), Vertex ...
Vertex Pharmaceuticals stock (NASDAQ: VRTX) is trending higher after the U.S. FDA approved Journavx – an oral non-opioid pain medication. This is a big win for Vertex, given that Journavx can ...
The U.S. Food and Drug Administration has approved a new non-opioid pain medication developed by Boston-based Vertex Pharmaceuticals. The drug, which is called suzetrigine and will be sold under ...
Vertex Pharmaceuticals Incorporated (VRTX) is a global biotechnology leader specializing in the development of innovative therapies for serious diseases. Headquartered in Boston, Massachusetts ...